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Our entry into what was going to become the field of gene targeting began in 1977. I was 
experimenting with the use of extremely small glass needles to inject DNA directly into the nuclei of 
living cells. The needles were controlled by hydraulically driven micro-manipulators and were 
directed into nuclei with the aid of a microscope. Using this experimental paradigm, I asked myself 
whether I could introduce a functional gene into cells by injecting the DNA directly into their nuclei. 
This procedure turned out to be extremely efficient. One in three cells received the DNA in 
functional form and went on to divide and stably pass the gene onto its daughter cells (Capecchi, 
1980). The high efficiency of micro-injection meant that it was now practical to use this technology 
to generate transgenic mice by the injection of DNA into one-cell zygotes. The embryos were then 
allowed to come to term by surgical transfer of the zygote to foster mothers. Indeed, this has become 
a cottage industry in many laboratories throughout the world (Gordon et al., 1980; Costantini and 
Lacy, 1981; Brinsteretal., 1981; Wagner,E.P. etal., 1981; Wagner, T.e. etal., 1981). However, 
generation of transgenic animals in this way involves the introduction of exogenous DNA segments at 
unpredictable locations in the recipient genome, and not targeted genetic alterations at defined sites. 
I was personally fascinated by the following observation from these early micro-injection 
experiments. Although multiple copies of a DNA segment were integrated into a random location 
within the host chromosome when they were injected into a cell, they were always present in 
head-to-tail concatemers. Such highly ordered concatemers could be generated in two ways: (I) by 
replication, for example by a rolling circle type mechanism; or (2) by homologous recombination. 
We were able to prove unambiguously that the concatemers were generated by homologous 
recombination (Folger et al., 1982). The significance of this observation was its demonstration that 
mammalian cells contain an efficient machinery for mediating homologous recombination. At the 
time, this was a startling discovery, because it was always assumed that the function of homologous 
recombination in all organisms, simple or complex, was to ensure broad dissemination of the parental 
genetic traits to their offspring by shuffling these traits in the germ cells. Finding evidence for this 
activity in mouse fibroblast cells implied that all cells, somatic as well as germ cells, were capable of 
mediating homologous recombination. The machinery in somatic cells appeared to be very efficient, 
since I could inject over 100 copies of a DNA sequence into a cell nucleus and they were all neatly 
incorporated into a single, ordered, head-to-tail concatemer. I realised immediately that, if I could 
harness this machinery to carry out homologous recombination between a newly introduced DNA 
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molecule of our choice and the same DNA sequence in the cell's chromosome, I would have the 
ability to mutate at will any specific gene in the living cell. 
Homologous recombination between two similar DNA molecules involves the breaking and rejoining 
of these molecules. The exchange is done with such precision that the DNA sequence at the point of 
exchange is not altered. If one of the DNA molecules has a mutation or alteration relative to the 
other, then the modification is transferred to the other DNA molecule during the exchange. Gene 
targeting involves the transfer of a designed alteration in an exogenous DNA sequence to the cognate 
DNA sequence in the living cell genome via homologous recombination. 
We spent the next few years in my laboratory becoming familiar with the machinery that mediates 
homologous recombination in mammalian cells in order to determine its likes and dislikes so that we 
could exploit this machinery for our purpose of gene targeting. In 1980, I submitted a National 
Institutes of Health (NIH) grant application outlining experiments intended to test the feasibility of 
gene targeting in mammalian cells. This part of the grant was soundly rejected. In the reviewers' 
opinion, the probability that the newly introduced DNA would ever find its matching sequence within 
the host genome was very small and, therefore, the experiments were not worthy of pursuit. Despite 
this rejection, I decided to forge ahead with these experiments using a paradigm that was capable of 
detecting gene-targeting events at a very low frequency. Once we observed a gene-targeting event, 
we could optimise the conditions to improve its efficiency. By 1984, we were confident that it was 
feasible to do gene targeting in cultured mammalian cells, and 1 presented our work at a memorable 
symposium on homologous recombination held at the Cold Spring Harbor Laboratory (Folger et al., 
1984). We resubmitted our grant application to the NIH. This time, the grant proposal was received 
with enthusiasm, and the new critique started with the words, "We are glad that you didn't follow our 
advice". 
The next question we pursued was whether gene targeting could be extended to a whole animal, 
i.e. the mouse. Because of the low frequency of targeting events in mammalian cells, it was clear that 
doing the experiments directly in mouse zygotes would not be practical. Rather, targeting events had 
to be identified first in cultured cells to allow purification of a clonal cell line containing the desired 
gene disruption; these cells in turn could be used to generate mice capable of transmitting the 
mutation in their germline. I was familiar with the frustrations associated with previous attempts to 
obtain germline chimeras using embryonal carcinoma (EC) cells. However, in the summer of 1984 at 
a Gordon Conference, I heard a discussion of EK cells that appeared to be much more promising in 
their potential for contributing to the germline. EK cells, which were developed in Martin Evans' 
laboratory in Cambridge, United Kingdom, differed from EC cells in that they were obtained from the 
early mouse embryo, rather than from mouse tumours (Evans and Kaufman, 1981). In the winter of 
1985, I arranged to spend a week in Martin Evans' laboratory to learn how to culture and manipulate 
mouse EK cells. It was just before Christmas, a marvellous time to be in Cambridge. 
By early 1986, our total efforts were focused on EK cells, now known as embryonal stem (ES) cells. 
We also decided to use electroporation, rather than micro-injection, as a means of introducing the 
targeting vector into cells. Although micro-injection was orders of magnitude more efficient than 
electroporation for this purpose, injections had to be done one cell at a time and 1 was getting tired of 
doing micro-injections. With electroporation, 108 cells could be manipulated in a single experiment. 
I also thought that the use of the easier electroporation approach would help facilitate the transfer of 
the gene-targeting technology to other investigators. The gene that we chose to disrupt in ES cells 
was hprt, because it provided us with the luxury of being able to select directly for cells containing 




deri ved from a male mouse. only a s ing le locus had to be d isrupted in order to yield IIprt defecti ve 
cell s. The stralegy that we employed was to use a neomycin-resistance gene (neo') to disrupt the IIpr' 
genomic sequences. then to select fo r cell s resistant to both G4 18. a neo myc in analogue, and 
6-thioguanine (6-TG), a drug toxic to ce lls wit h a functional IIprt gene. All such selected ce ll lines 
had lost IIpr! enzymatic acti vity as a result of targeted d isruption of the IIprt locus. These experiments 
showed that ES cell s were indeed able to mediate homologous recombination, and that the selection 
protoco ls requi red to identify ce ll lines containing the targeted di sruption did not al ter their 
pluripotenl state in culture (Thomas and Capecchi , 1987). This system also provided a good 
experi mental paradigm for explo ring the parameters thai affect the effi ciency of gene targeting. I 
believe that this study played a pivotal role in the development o f the fie ld by encou raging Olher 
investigators to now begin using ge ne targeting as a mean s of determining the fu nction of genes in 
mammals. 
Although mammalian cells have the machinery to direct the newly introduced DNA to its endogenous 
target, we found that the targeti ng vector was al so in serted into random sites withi n the host genome 
by non-homologous recombi nation . The rati o of homologous to non-homologous recombi nation 
events is approx imately 1 to 1 000. Since di sruption of most genes is not expected to produce a 
phenotype selectable at the cellular level, an in vesti gator seeking a spec ifi c di srupti on must either 
screen through many colonies of cells in order to identify the rare co lony that contai ns the des ired 
targeti ng event, or use selections that enri ch for cells conta ining the targeting event. Late in 1986. I 
conceived of a general strategy to enrich for cell s in which a targetin g event had occurred. It was 
based on key observalions made during our studies o f recombination involving exogenous DNA in 
mammalian cells. Incorporation of DNA segments at random non-homologous s ites invol ves 
insertions of a linearised vector through its ends, whereas recombinat ion aI a homologous target site 
involves crossover events occurring only through homologous seq uences in the vector. Our strategy 
based on these observations, and known as positj ve-negative selection (PNS), uses two components. 
One component is a "positive selectable" gene, ned , used as a marker to select f or ce lls that have 
incorporated the targeting vector anywhere in the rec ipient cell genome (i.e . at the target site via 
homologous recombination or at random sites via non-homologous reco mbination). The second 
component is a " negative se lectable" gene, located at o ne end of the lineari sed targeting vector. used 
to se lect agaimI cell s that contai n random insertio ns of the targeting vector. The net effect is to 
en rich for ce lls in which the desired homologous targeting event has occ urred. The strength of thi s 
e nrichment procedure is that it is independent of the function of the gene and succeeds whether or not 
the gene is expressed in the recipient ES cell s (Mansour el al., 1988). PNS is now the most frequen tl y 
used procedure for enrichment o f cell s containing gene-targeting even ts. The origin of the idea for 
positive-negative se lection was not very romantic and involved pure ly ded uctive reasoning. 
Enrichment for ce ll s containing the targeting e vent could be achi eved either by direct selection for 
cell s containing the targeti ng event or by e limination of cell s that contained random insertions of the 
targeting vector. This fact, coupled with an appreciation o f how info rmati on is transfe rred between 
an exogenous and an endogenous DNA sequence via homologous and non-homologous 
recombination , naturall y led to the concept of positi ve-negat ive selection . 
Once ES cell s with the desired mutati on are obtained. how are they used to generate mice with the 
targeted mutation in all of their ce lls? Brie ny, the ES cells carrying the targeted di sruption are 
injected into an earl y. pre-implantation mouse embryo. the blastocyst The blastocyst is then 
surg ically transferred in to the uteru s of a foster mother to allow the embryo to come to term. ES cell s 
are pluri potent, i.e. capable o f g iving ri se to all cell types in the embryo. In the embryonic 
environmen t, these ce lls parti cipate in forming all mouse tissues. most importantly the germ cell s. If 
the source of the recipient blastocyst and the ES cells are mice of distinguishable coat colours, then 
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the resulting mouse is recognisable, because its coat will have stripes of both colours. Such mice, 
with cells of more than one genotype, are known as chimeras. If the chimera is a male, some or all of 
the sperm are likely to be derived from the ES cells that carry the targeted mutation. On breeding, the 
mutation will be transmitted, on average, to half of the offspring. These heterozygotes will be healthy 
in most instances, because their second, undamaged copy of the gene will still function properly. But 
mating of heterozygotes to brothers or sisters bearing the same mutation yields homozygotes: 
animals carrying the targeted mutation in both copies of the gene. Such animals will display 
abnormalities that help to reveal the normal function of the disrupted gene. 
The use of gene targeting to evaluate the functions of genes in the living mouse is now a routine 
procedure. It is very gratifying to be able to pick up almost any major journal in the biological 
sciences and find the description of yet another gene "knock-out" mouse. In the past five years, the 
in vivo functions of over 300 genes have been determined with this approach. It is relatively easy to 
project where gene-targeting technology will go in the near future. It will continue to serve as the 
way to determine the roles of individual genes in mammalian biology. This will be accomplished by 
the generation of null mutations knocking out the genes of interest. Those investigators who desire 
deeper insights will generate an allelic series of mutations in a chosen gene to evaluate the effects of 
partial loss-of-function as well as gain-of-function mutations. To permit evaluation of potential 
multiple roles of a gene in different tissues, gene targeting will be used to engineer tissue-specific 
gene disruptions using the cre/loxP system (Gu et ai., 1994). Further, the technology soon should 
become available that will allow the investigator to turn chosen genes on or off in the adult or during 
any phase of mouse development. Finally, since most biological processes are mediated by 
interactions among a number of genes, such phenomena will be studied by combining multiple 
targeted mutations in a single mouse. There is no question that the mouse is a very complex 
organism. However, the broad range of genetic manipulations that are now available through gene 
targeting should provide a means for us to begin deciphering even the most complex of biological 
processes including development and learning. 
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